Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1'
(id=7597933 ; fe=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=10374 creation date=2017-06-29 touchdate=2025-12-18 16:12:59.000)
≈ 56 relations sortantes

  1. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 26 / 1 -> leucémie
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=leucémie | rel=r_associated | relid=0 | w=26
  2. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 25 / 0.962 -> en:acute
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=en:acute | rel=r_associated | relid=0 | w=25
  3. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 24 / 0.923 -> en:acute basophilic leukemia
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=en:acute basophilic leukemia | rel=r_associated | relid=0 | w=24
  4. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 24 / 0.923 -> en:acute megakaryoblastic leukemia
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=en:acute megakaryoblastic leukemia | rel=r_associated | relid=0 | w=24
  5. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> en:acute erythroid leukemia
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=en:acute erythroid leukemia | rel=r_associated | relid=0 | w=20
  6. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> en:acute monocytic leukemia
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=en:acute monocytic leukemia | rel=r_associated | relid=0 | w=20
  7. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> en:acute myeloblastic leukaemia
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=en:acute myeloblastic leukaemia | rel=r_associated | relid=0 | w=20
  8. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> en:acute myeloblastic leukemia
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=en:acute myeloblastic leukemia | rel=r_associated | relid=0 | w=20
  9. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> en:acute myeloid leukemia
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=en:acute myeloid leukemia | rel=r_associated | relid=0 | w=20
  10. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> en:acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13); rbm15-mkl1
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=en:acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13); rbm15-mkl1 | rel=r_associated | relid=0 | w=20
  11. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> en:acute myeloid leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); cbfb-myh11
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=en:acute myeloid leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); cbfb-myh11 | rel=r_associated | relid=0 | w=20
  12. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> en:acute myeloid leukemia with maturation
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=en:acute myeloid leukemia with maturation | rel=r_associated | relid=0 | w=20
  13. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> en:acute myeloid leukemia with minimal differentiation
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=en:acute myeloid leukemia with minimal differentiation | rel=r_associated | relid=0 | w=20
  14. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> en:acute myeloid leukemia with multilineage dysplasia
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=en:acute myeloid leukemia with multilineage dysplasia | rel=r_associated | relid=0 | w=20
  15. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> en:acute myeloid leukemia with t(6;9)(p23;q34); dek-nup214
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=en:acute myeloid leukemia with t(6;9)(p23;q34); dek-nup214 | rel=r_associated | relid=0 | w=20
  16. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> en:acute myeloid leukemia with t(8;21)(q22;q22); runx1-runx1t1
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=en:acute myeloid leukemia with t(8;21)(q22;q22); runx1-runx1t1 | rel=r_associated | relid=0 | w=20
  17. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> en:acute myeloid leukemia with t(9;11)(p22;q23); mllt3-mll
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=en:acute myeloid leukemia with t(9;11)(p22;q23); mllt3-mll | rel=r_associated | relid=0 | w=20
  18. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> en:acute myeloid leukemia without maturation
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=en:acute myeloid leukemia without maturation | rel=r_associated | relid=0 | w=20
  19. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> en:acute panmyelosis with myelofibrosis
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=en:acute panmyelosis with myelofibrosis | rel=r_associated | relid=0 | w=20
  20. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> en:acute promyelocytic leukemia with t(15;17)(q22;q12); pml-rara
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=en:acute promyelocytic leukemia with t(15;17)(q22;q12); pml-rara | rel=r_associated | relid=0 | w=20
  21. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> en:atypical chronic myeloid leukemia, bcr-abl1 negative
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=en:atypical chronic myeloid leukemia, bcr-abl1 negative | rel=r_associated | relid=0 | w=20
  22. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> en:chronic eosinophilic leukemia, not otherwise specified
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=en:chronic eosinophilic leukemia, not otherwise specified | rel=r_associated | relid=0 | w=20
  23. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> en:hairy cell leukemia
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=en:hairy cell leukemia | rel=r_associated | relid=0 | w=20
  24. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> en:mast cell leukemia
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=en:mast cell leukemia | rel=r_associated | relid=0 | w=20
  25. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> en:myeloid leukemia
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=en:myeloid leukemia | rel=r_associated | relid=0 | w=20
  26. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> en:myeloid leukemia associated with down syndrome
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=en:myeloid leukemia associated with down syndrome | rel=r_associated | relid=0 | w=20
  27. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> en:myeloid sarcoma
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=en:myeloid sarcoma | rel=r_associated | relid=0 | w=20
  28. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> en:other myeloid leukaemia
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=en:other myeloid leukaemia | rel=r_associated | relid=0 | w=20
  29. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> en:philadelphia chromosome positive, bcr-abl1 positive chronic myelogenous leukemia
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=en:philadelphia chromosome positive, bcr-abl1 positive chronic myelogenous leukemia | rel=r_associated | relid=0 | w=20
  30. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> la à granulocytes
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=la à granulocytes | rel=r_associated | relid=0 | w=20
  31. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> LA à granulocytes
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=LA à granulocytes | rel=r_associated | relid=0 | w=20
  32. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> lam
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=lam | rel=r_associated | relid=0 | w=20
  33. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> lanl
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=lanl | rel=r_associated | relid=0 | w=20
  34. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> leucémie à mastocytes
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=leucémie à mastocytes | rel=r_associated | relid=0 | w=20
  35. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> leucémie aigüe à basophiles
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=leucémie aigüe à basophiles | rel=r_associated | relid=0 | w=20
  36. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> leucémie aiguë granulocytaire
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=leucémie aiguë granulocytaire | rel=r_associated | relid=0 | w=20
  37. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> leucémie aiguë myéloblastique
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=leucémie aiguë myéloblastique | rel=r_associated | relid=0 | w=20
  38. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> leucémie aigüe myéloblastique
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=leucémie aigüe myéloblastique | rel=r_associated | relid=0 | w=20
  39. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> leucémie aiguë myélocytaire
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=leucémie aiguë myélocytaire | rel=r_associated | relid=0 | w=20
  40. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> leucémie aiguë myéloïde
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=leucémie aiguë myéloïde | rel=r_associated | relid=0 | w=20
  41. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> leucémie aigüe myéloïde
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=leucémie aigüe myéloïde | rel=r_associated | relid=0 | w=20
  42. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> leucémie aigüe non lymphoblastique
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=leucémie aigüe non lymphoblastique | rel=r_associated | relid=0 | w=20
  43. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> leucémie aiguë non lymphoblastique
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=leucémie aiguë non lymphoblastique | rel=r_associated | relid=0 | w=20
  44. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> leucémie aiguë non lymphocytaire
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=leucémie aiguë non lymphocytaire | rel=r_associated | relid=0 | w=20
  45. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> leucémie blastique granulocytaire
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=leucémie blastique granulocytaire | rel=r_associated | relid=0 | w=20
  46. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> leucémie granuleuse aiguë
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=leucémie granuleuse aiguë | rel=r_associated | relid=0 | w=20
  47. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> leucémie granulocytaire aiguë
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=leucémie granulocytaire aiguë | rel=r_associated | relid=0 | w=20
  48. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> leucémie myéloblastique aiguë
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=leucémie myéloblastique aiguë | rel=r_associated | relid=0 | w=20
  49. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> leucémie myéloblastique aigüe
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=leucémie myéloblastique aigüe | rel=r_associated | relid=0 | w=20
  50. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> leucémie myélocytaire aiguë
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=leucémie myélocytaire aiguë | rel=r_associated | relid=0 | w=20
  51. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> leucémie myélogène aigüe
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=leucémie myélogène aigüe | rel=r_associated | relid=0 | w=20
  52. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> leucémie myélogène aiguë
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=leucémie myélogène aiguë | rel=r_associated | relid=0 | w=20
  53. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> leucémie myéloïde aigüe
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=leucémie myéloïde aigüe | rel=r_associated | relid=0 | w=20
  54. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> leucémie myéloïde aiguë
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=leucémie myéloïde aiguë | rel=r_associated | relid=0 | w=20
  55. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> leucémie non lymphoblastique aiguë
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=leucémie non lymphoblastique aiguë | rel=r_associated | relid=0 | w=20
  56. en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 -- r_associated #0: 20 / 0.769 -> leucémies myéloïdes aiguës
    n1=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | n2=leucémies myéloïdes aiguës | rel=r_associated | relid=0 | w=20
≈ 63 relations entrantes

  1. lanl --- r_associated #0: 410 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=lanl | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=410
  2. leucémie myéloïde aiguë --- r_associated #0: 410 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=leucémie myéloïde aiguë | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=410
  3. lam --- r_associated #0: 401 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=lam | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=401
  4. la à granulocytes --- r_associated #0: 390 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=la à granulocytes | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=390
  5. leucémie aiguë myélocytaire --- r_associated #0: 390 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=leucémie aiguë myélocytaire | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=390
  6. leucémie aiguë non lymphoblastique --- r_associated #0: 390 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=leucémie aiguë non lymphoblastique | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=390
  7. leucémie aiguë non lymphocytaire --- r_associated #0: 390 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=leucémie aiguë non lymphocytaire | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=390
  8. leucémie aigüe myéloblastique --- r_associated #0: 390 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=leucémie aigüe myéloblastique | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=390
  9. leucémie granuleuse aiguë --- r_associated #0: 390 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=leucémie granuleuse aiguë | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=390
  10. leucémie granulocytaire aiguë --- r_associated #0: 390 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=leucémie granulocytaire aiguë | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=390
  11. leucémie non lymphoblastique aiguë --- r_associated #0: 390 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=leucémie non lymphoblastique aiguë | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=390
  12. en:acute myeloid leukemia --- r_associated #0: 386 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=en:acute myeloid leukemia | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=386
  13. leucémie myélogène aiguë --- r_associated #0: 370 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=leucémie myélogène aiguë | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=370
  14. leucémie aigüe non lymphoblastique --- r_associated #0: 360 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=leucémie aigüe non lymphoblastique | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=360
  15. leucémie myéloblastique aiguë --- r_associated #0: 360 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=leucémie myéloblastique aiguë | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=360
  16. leucémie myélogène aigüe --- r_associated #0: 360 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=leucémie myélogène aigüe | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=360
  17. leucémie blastique granulocytaire --- r_associated #0: 355 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=leucémie blastique granulocytaire | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=355
  18. leucémie myéloïde aigüe --- r_associated #0: 345 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=leucémie myéloïde aigüe | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=345
  19. leucémie aiguë granulocytaire --- r_associated #0: 335 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=leucémie aiguë granulocytaire | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=335
  20. leucémie aigüe myéloïde --- r_associated #0: 335 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=leucémie aigüe myéloïde | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=335
  21. leucémie myélocytaire aiguë --- r_associated #0: 335 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=leucémie myélocytaire aiguë | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=335
  22. leucémies myéloïdes aiguës --- r_associated #0: 320 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=leucémies myéloïdes aiguës | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=320
  23. leucémie aiguë myéloïde --- r_associated #0: 315 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=leucémie aiguë myéloïde | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=315
  24. leucémie aiguë myéloblastique --- r_associated #0: 300 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=leucémie aiguë myéloblastique | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=300
  25. leucémie myéloblastique aigüe --- r_associated #0: 300 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=leucémie myéloblastique aigüe | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=300
  26. LA à granulocytes --- r_associated #0: 90 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=LA à granulocytes | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=90
  27. en:acute myeloblastic leukaemia --- r_associated #0: 90 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=en:acute myeloblastic leukaemia | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=90
  28. en:acute myeloblastic leukemia --- r_associated #0: 63 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=en:acute myeloblastic leukemia | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=63
  29. en:mast cell leukemia --- r_associated #0: 45 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=en:mast cell leukemia | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=45
  30. leucémie à mastocytes --- r_associated #0: 43 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=leucémie à mastocytes | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=43
  31. en:myeloid leukemia associated with down syndrome --- r_associated #0: 40 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=en:myeloid leukemia associated with down syndrome | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=40
  32. leucémie aigüe à basophiles --- r_associated #0: 39 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=leucémie aigüe à basophiles | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=39
  33. en:acute basophilic leukemia --- r_associated #0: 37 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=en:acute basophilic leukemia | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=37
  34. en:acute megakaryoblastic leukemia --- r_associated #0: 35 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=en:acute megakaryoblastic leukemia | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=35
  35. en:acute myeloid leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); cbfb-myh11 --- r_associated #0: 35 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=en:acute myeloid leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); cbfb-myh11 | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=35
  36. en:acute myeloid leukemia with t(8;21)(q22;q22); runx1-runx1t1 --- r_associated #0: 35 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=en:acute myeloid leukemia with t(8;21)(q22;q22); runx1-runx1t1 | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=35
  37. en:chronic eosinophilic leukemia, not otherwise specified --- r_associated #0: 35 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=en:chronic eosinophilic leukemia, not otherwise specified | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=35
  38. en:acute myeloid leukemia with multilineage dysplasia --- r_associated #0: 34 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=en:acute myeloid leukemia with multilineage dysplasia | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=34
  39. en:acute myeloid leukemia with t(9;11)(p22;q23); mllt3-mll --- r_associated #0: 34 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=en:acute myeloid leukemia with t(9;11)(p22;q23); mllt3-mll | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=34
  40. en:acute panmyelosis with myelofibrosis --- r_associated #0: 34 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=en:acute panmyelosis with myelofibrosis | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=34
  41. en:atypical chronic myeloid leukemia, bcr-abl1 negative --- r_associated #0: 34 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=en:atypical chronic myeloid leukemia, bcr-abl1 negative | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=34
  42. en:myeloid sarcoma --- r_associated #0: 32 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=en:myeloid sarcoma | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=32
  43. en:acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13); rbm15-mkl1 --- r_associated #0: 31 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=en:acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13); rbm15-mkl1 | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=31
  44. en:acute myeloid leukemia with maturation --- r_associated #0: 30 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=en:acute myeloid leukemia with maturation | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=30
  45. en:acute myeloid leukemia with minimal differentiation --- r_associated #0: 30 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=en:acute myeloid leukemia with minimal differentiation | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=30
  46. en:acute myeloid leukemia with t(6;9)(p23;q34); dek-nup214 --- r_associated #0: 29 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=en:acute myeloid leukemia with t(6;9)(p23;q34); dek-nup214 | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=29
  47. en:acute monocytic leukemia --- r_associated #0: 28 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=en:acute monocytic leukemia | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=28
  48. en:acute myeloid leukemia without maturation --- r_associated #0: 28 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=en:acute myeloid leukemia without maturation | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=28
  49. en:acute erythroid leukemia --- r_associated #0: 27 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=en:acute erythroid leukemia | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=27
  50. en:other myeloid leukaemia --- r_associated #0: 27 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=en:other myeloid leukaemia | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=27
  51. en:philadelphia chromosome positive, bcr-abl1 positive chronic myelogenous leukemia --- r_associated #0: 27 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=en:philadelphia chromosome positive, bcr-abl1 positive chronic myelogenous leukemia | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=27
  52. en:acute promyelocytic leukemia with t(15;17)(q22;q12); pml-rara --- r_associated #0: 26 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=en:acute promyelocytic leukemia with t(15;17)(q22;q12); pml-rara | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=26
  53. en:hairy cell leukemia --- r_associated #0: 26 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=en:hairy cell leukemia | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=26
  54. en:myeloid leukemia --- r_associated #0: 26 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=en:myeloid leukemia | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=26
  55. LaM --- r_associated #0: 25 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=LaM | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=25
  56. leucémie à tricholeucocyte --- r_associated #0: 21 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=leucémie à tricholeucocyte | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=21
  57. Leucémie myéloïde aiguë --- r_associated #0: 20 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=Leucémie myéloïde aiguë | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=20
  58. leucémie --- r_associated #0: 20 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=leucémie | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=20
  59. Leucémie aigüe myéloïde --- r_associated #0: 15 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=Leucémie aigüe myéloïde | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=15
  60. leucémie à tricholeucocytes --- r_associated #0: 11 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=leucémie à tricholeucocytes | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=11
  61. LANL --- r_associated #0: 10 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=LANL | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=10
  62. Leucémie aiguë myéloblastique --- r_associated #0: 10 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=Leucémie aiguë myéloblastique | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=10
  63. leucémie à grands lymphocytes granuleux (LGL) --- r_associated #0: 10 --> en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1
    n1=leucémie à grands lymphocytes granuleux (LGL) | n2=en:acute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); rpn1-evi1 | rel=r_associated | relid=0 | w=10
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr